Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma

Hormone Research

Volumn 62, Issue 2, 2004, Pages 67-70

  Kurtulmus, Neslihan ^a,c   Yarman, Sema ^a   Azizlerli, Halil ^a   Kapran, Yersu ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Adrenocortical carcinoma; Hyperaldosteronism; Hypokalemia

Indexed keywords

ALDOSTERONE; DEXAMETHASONE; HYDROCORTISONE;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; ANAMNESIS; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL FEATURE; CUSHING DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; ENDOCRINOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE RELEASE; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; ALDOSTERONE; DIURETICS; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPOKALEMIA; SPIRONOLACTONE;

EID: 4644231614     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079322     Document Type: Article

References (11)

1. Ng L, Libertino JM: Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol 2003;169:5-11.
2. Bodie B, Novick CA, Pontes EJ, Straffon AR, Montie JE, Babiak T, Sheeler L, Schumacher P: The Cleveland Clinic Experience with Adrenocortical Carcinoma. J Urol 1989;141:257-260.
3. Wajchenberg BL, Albergaria PM, Medonca BB, Latronica AC, Campos CP, Ferreira Alves VA, Zerbini MC, Liberman B, Carlos GG, Kirschner MA: Adrenocortical carcinoma: Clinical and laboratory observations. Cancer 2000;88:711-736.
4. Weingartner K, Gerharz EW, Bittinger A, Rosai J, Leppek R, Riedmiller H: Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma: Case report and review of the literature. Urol Int 1995;55:232-235.
5. Stone NN, Janoski A, Muakkassa W, Shpritz L: Mineralocorticoid excess secondary to adrenal cortical carcinoma. J Urol 1984;132:962-965.
6. Slee JTHH, Schaberg A, Brummelen P: Carcinoma of the adrenal cortex causing primary hyperaldosteronism. Cancer 1983;51:2341-2345.
7. Stratakis CA, Chrousos GP: Adrenal cancer. Endocrinol Metab Clin North Am 2000;29:15-25.
8. Yoshimoto T, Naruse M, Ito Y, Naruse K, Ueda T, Tanabe A, Harada S, Nishikawa T, Sasano H, Obara T, Demura H: Adrenocortical carcinoma manifesting pure primary aldosteronism: A case report and analysis of steroidogenic enzymes. J Endocrinol Invest 2000;23:112-117.
9. Farge D, Pagny JY, Chatallier G, Plouin PF, Corvol P: Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism. Arch Mal Coeur Vaiss 1988;81:83-87.
10. Komiya I , Koizumi Y, Kobayashi R , Kotani M, Yamada T, Maruyama Y: Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma. Am J Med 1979;67:516-518.
11. Honda T, Nakamura T, Saito Y, Ohyama Y, Sumino H, Kurabayashi M: Combined primary aldosteronism and preclinical Cushing's syndrome: An unusual case presentation of adrenal adenoma. Hypertens Res 2001;24:723-726.